Video

Michael Bloch, MD, on Hypercholesterolemia: A Focus on PCSK9 Inhibitors

11/19/2019

In this video, Michael Bloch, MD, talks about his session at the Cardiometabolic Risk Summit 2019, which reviewed the latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, assessed current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and more.

Related Content

Gastroenterology
Gastroenterology
New Therapies That Target the JAK-STAT Pathway and Other Small Molecules
08/08/2018
08/08/2018
Stress and Burnout
Stress and Burnout
Garret Duron, MD, on How to Successfully Navigate the COVID-19 Literature Landscape
11/11/2020
In this video, Garret Duron, MD, highlights the 3 main literature-based challenges that rheumatologists are facing during the COVID-19 pandemic and offers recommendations on how to overcome those...
11/11/2020
Surgery
Surgery
Robotic-Arm Assisted Surgery for Hip & Knee Replacements Provides Actionable Intra-Operative Data
08/02/2019
Michael H. Rieber, MD, discusses robotic-arm assisted surgery using a system that is currently FDA-approved for total hip replacement, as well as for partial and total knee replacement surgeries.
08/02/2019
Infectious Diseases
Infectious Diseases
Steven Grinspoon, MD, on the Association Between HIV and Steatosis
03/11/2021
In this video, Steven Grinspoon, MD, talks about the association between HIV and Steatosis and why patients with HIV are at an increased risk of steatosis.
03/11/2021
Hypertension
James Matera, DO, FACOI
Hypertension
CRS 2016: James Matera, DO, on Complex Hypertensive Cases
08/29/2016
James Matera, DO, FACOI, is a practicing nephrologist at Nephrology Hypertension Associates of Central New Jersey and co-director of Physician Integration at CentraState Medical Center in Freehold, NJ....
08/29/2016